よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


「日本人の食事摂取基準(2025年版)」策定検討会報告書 (439 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_44138.html
出典情報 「日本人の食事摂取基準(2025年版)」策定検討会報告書(10/11)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

disease risks: Meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol. 2018;3(3):225-234.
36) Hu Y, Hu FB, Manson JE. Marine omega-3 supplementation and cardiovascular disease: An updated metaanalysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc.
2019;8(19):e013543.
37) Alexander DD, Miller PE, Van Elswyk ME, et al. A meta-analysis of randomized controlled trials and
prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and
coronary heart disease risk. Mayo Clin Proc. 2017;92(1):15-29.
38) Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease
among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation.
2006;113(2):195-202.
39) Yamagishi K, Iso H, Date C, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from
cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC
(Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol.
2008;52(12):988-996.
40) Miyagawa N, Miura K, Okuda N, et al. Long-chain n-3 polyunsaturated fatty acids intake and cardiovascular
disease mortality risk in Japanese: a 24-year follow-up of NIPPON DATA80. Atherosclerosis.
2014;232(2):384-389.
41) Connor WE, Connor SL. Dietary cholesterol and coronary heart disease. Curr Atheroscler Rep.
2002;4(6):425-432.
42) Dietschy JM, Turley SD, Spady DK. Role of liver in the maintenance of cholesterol and low density
lipoprotein homeostasis in different animal species, including humans. J Lipid Res. 1993;34(10):1637-1659.
43) Stellaard F, Lütjohann D. The interpretation of cholesterol balance derived synthesis data and surrogate
noncholesterol plasma markers for cholesterol synthesis under lipid lowering therapies. Cholesterol.
2017;2017:5046294.
44) Mistry P, Miller NE, Laker M, et al. Individual variation in the effects of dietary cholesterol on plasma
lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity
and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. J Clin Invest.
1981;67(2):493-502.
45) Katan MB, Beynen AC. Hyper-response to dietary cholesterol in man. Lancet. 1983;1(8335):1213.
46) Wolff E, Vergnes MF, Portugal H, et al. Cholesterol-absorber status modifies the LDL cholesterol-lowering
effect of a Mediterranean-type diet in adults with moderate cardiovascular risk factors. J Nutr.
2011;141(10):1791-1798.
47) Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce
cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force
on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76-99.
48) U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines
for Americans, 2020-2025. 9th ed. U.S. Department of Agriculture, Washington, D.C.; 2020.
49) Zhong VW, Van Horn L, Cornelis MC, et al. Associations of dietary cholesterol or egg consumption with
incident cardiovascular disease and mortality. JAMA. 2019;321(11):1081-1095.
50) 厚生労働省. 令和元年国民健康・栄養調査報告.

429